[
    [
        {
            "time": "2023-10-05",
            "original_text": "Urbem's Quality Strategy Series: The Qualitative Traits",
            "features": {
                "keywords": [
                    "Urbem",
                    "Quality Strategy",
                    "Qualitative Traits"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "general finance"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Urbem's Quality Strategy Series: The Qualitative Traits",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-10-05",
            "original_text": "Hedge Funds Are Buying Novo Nordisk A/S (NVO)",
            "features": {
                "keywords": [
                    "Hedge Funds",
                    "Buying",
                    "Novo Nordisk",
                    "NVO"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Hedge Funds Are Buying Novo Nordisk A/S (NVO)",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]